This milestone expands patient eligibility through multi-HLA targetingBuilds on completed TVGN 489 trial demonstrating 100% viral clearance, no reinfections, and no cases of Long COVID in high-risk pa ...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...
Tevogen (TVGN) announced a clinical milestone in the evolution of its proprietary ExacTcell platform: completion of T cell target identification ...
FRIDAY, Oct. 31, 2025 (HealthDay News) — A new gene test might be able to predict which gout patients will have a bad skin ...
A recent study discovered that a new gene test may assist predict which gout patients could suffer dangerous skin reactions ...
In a recent study published in Nature Medicine, a team of researchers from the United Kingdom (U.K.) used data from clinical trials of the Oxford-AstraZeneca coronavirus disease 2019 (COVID-19) ...
The "United States Molecular Diagnostics Market, Test Volume Forecast & Companies: Oncology Test (Breast, Colorectal, Prostate) Infectious Diseases Test (Virology, HPV, HAI, Critical Care) Genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback